Triple Negative Breast Cancer Plasma
About: Triple Negative Breast Cancer Plasma - Cryopreserved human plasma collected from clinically confirmed triple negative breast cancer donors. Triple negative breast cancer plasma is ideal for biomarker discovery and developing new treatment strategies.
Triple Negative Breast Cancer Plasma | High-Quality Human Plasma from Triple Negative Breast Cancer Donors
Triple Negative Breast Cancer Plasma is collected from donors clinically diagnosed with triple negative breast cancer (TNBC) and processed within hours of collection to preserve key analytes such as cytokines, proteins, and metabolites. This human triple negative breast cancer plasma supports research focused on biomarker discovery and monitoring, and treatment development for TNBC.
Product Features
- Research Use Only (RUO)
- TNBC plasma collected from clinically confirmed donors
- Processed within one day of collection
- IRB-approved protocols and informed consent
- Custom aliquot volumes available upon request
De-identified Donor Data
- Verified triple negative breast cancer diagnosis
- Demographic data: age, sex assigned at birth, race/ethnicity
- Donor-reported medications, allergies, and comorbidities
- Additional triple negative breast cancer-specific metadata available
Applications
- Biomarker discovery and validation
- Cytokine and inflammation profiling
- Metabolomics and proteomics studies
- Therapeutic response research
Compliance and Quality Assurance
- IRB-approved and HIPAA-compliant protocols
- Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
- Documentation support available for regulatory review
Ordering and Customization
Triple Negative Breast Cancer plasma is available in standard and custom volumes. For international orders or documentation requirements, please email learnmore@sanguinebio.com to ensure compatibility with your country’s regulations.
Protocols & Documentation
-
Download
Plasma Isolation
Protocol for plasma separation from anticoagulated whole blood, including processing, storage, and traceability requirements.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
Plasma
Frequently Asked Questions
1 Answer
YES – Comprehensive medical records are available and may contain information regarding autoantibody status.
1 Answer
YES – Sanguine offers both inventory for select conditions, as well as, prospective collection. For inventory visit https://sanguinebio.com/products/plasma/?pro_inventory=inventory.
1 Answer
We never thaw our plasma samples before shipping.
1 Answer
Our standard aliquot size for plasma is 1 mL but we have bulk plasma (50 to 150 mL) available for select conditions. https://sanguinebio.com/product/human-bulk-plasma/
1 Answer
YES – Sanguine bio provides “age-matched healthy controls” and longitudinal studies capabilities.
1 Answer
YES – custom age specifications available – The “Specify I/E Criteria” service allows you to define specific age ranges for donor selection.
1 Answer
Age ranges available – Donor metadata includes age specifications, and you can specify inclusion/exclusion criteria. For pediatric samples specifically, contact learnmore@sanguinebio.com.
Ask a Question
Need a custom Plasma cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.